Clin2
NCT06416397Likely a fitRecruiting

Bile test for bile duct cancer diagnosis

Cholangiocarcinoma

Part of Cancer clinical trials.

This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Age 18 or older
  • Have a narrowing (stenosis) in the bile duct
  • Need a procedure called endoscopic retrograde cholangiography or a radiology procedure to take tissue samples
  • Not be pregnant
  • Not be under legal guardianship

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06780553Not yet recruiting
Testing a new lab method for diagnosing bile duct cancer

This study is testing a new lab technique to see if it can accurately diagnose a type of bile duct cancer called cholangiocarcinoma from stored tissue samples. It might help doctors diagnose this cancer more accurately in the future.

Pessac
NCT07007832Recruiting
Bile test to diagnose unclear bile duct narrowings

This trial uses a bile sample to help diagnose the cause of a bile duct stricture (a narrowing) that was not clearly identified by standard tests. It may help patients avoid more invasive procedures.

Shanghai, China
NCT06658587Not yet recruiting
Blood test for early detection of bile duct cancer

This study is testing a new blood test to help find cholangiocarcinoma (bile duct cancer) earlier and more easily. If you are scheduled for surgery for this cancer, this test may help confirm the diagnosis without more invasive procedures.

Guangzhou, Guangdong
NCT06474091Enrolling by invitation
Blood monitoring for bile duct cancer treatment and outlook

This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.

Rochester, Minnesota
NCT06651346Not yet recruiting
New test for bile duct cancer during ERCP

This study looks at a new way to detect bile duct cancer (cholangiocarcinoma) using samples taken during a routine ERCP. It tests a special protein marker that might help doctors diagnose the condition more accurately.

Charlottesville, Virginia
NCT07206355Recruiting
Studying bile duct and liver lesions for new cancer tests

This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.

Nottingham

Hear when a new Cholangiocarcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.